Elotuzumab in Patients With Multiple Myeloma Before and After Peripheral Stem Cell Autologous Graft

Stopped Investigator decision in accordance with the promotor

Conditions

• Multiple Myeloma

Interventions

• DRUG: Elotuzumab

Sponsor

Assistance Publique - Hôpitaux de Paris